Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme.
complex II
disease
mitochondria
succinate dehydrogenase
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
09 Sep 2024
09 Sep 2024
Historique:
received:
09
07
2024
revised:
26
08
2024
accepted:
04
09
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
Succinate dehydrogenase (also known as complex II) plays a dual role in respiration by catalyzing the oxidation of succinate to fumarate in the tricarboxylic acid (TCA) cycle and transferring electrons from succinate to ubiquinone in the mitochondrial electron transport chain (ETC). Owing to the privileged position of SDH/CII, its dysfunction leads to TCA cycle arrest and altered respiration. This review aims to elucidate the widely documented profound metabolic effects of SDH/CII deficiency, along with the newly unveiled survival mechanisms in SDH/CII-deficient cells. Such an understanding reveals exploitable vulnerabilities for strategic targeting, which is crucial for the development of novel and more precise therapies for primary mitochondrial diseases, as well as for familial and sporadic cancers associated with SDH/CII mutations.
Identifiants
pubmed: 39335562
pii: biomedicines12092050
doi: 10.3390/biomedicines12092050
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Agencia Estatal de Investigación
ID : PID2020-118517RB-I00